Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Insulin Signaling WP481,1.9882171694866427e-06,3.552399766171461,46.636871148619186,"['MAP2K4', 'GSK3B', 'IRS1', 'PRKCB', 'STXBP4', 'PTEN', 'GAB1', 'PIK3R3', 'PIK3CD', 'FOS', 'IGF1R', 'GYS2', 'MAPK10', 'RPS6KA5', 'TBC1D4', 'PIK3CA', 'RPS6KA2', 'SOS1', 'MAP4K5', 'SOS2', 'MAP3K4', 'MAP4K3']",0.0005188790229028875,0,0,22
2,Focal Adhesion WP306,2.891608594839404e-06,3.245080137959018,41.38677077858005,"['VASP', 'VAV3', 'PDGFRB', 'ITGB1', 'GSK3B', 'LAMA5', 'PRKCB', 'PXN', 'PTEN', 'PIK3R3', 'VEGFC', 'PIK3CD', 'BRAF', 'LAMC1', 'IGF1R', 'MAPK10', 'RAP1A', 'PIK3CA', 'ITGA10', 'AKT3', 'ITGA8', 'ITGB8', 'ITGAV', 'SOS1']",0.0005188790229028875,0,0,24
3,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,3.6285246356845277e-06,4.782957721353393,59.91460201147457,"['PDGFRB', 'GSK3B', 'PRKCB', 'PTEN', 'GAB1', 'PIK3CD', 'PIK3R3', 'NRG1', 'BRAF', 'IGF1R', 'PIK3CA', 'AKT3', 'JAK2', 'SOS1', 'SOS2']",0.0005188790229028875,0,0,15
4,Phosphoinositides metabolism WP4971,7.588959176575217e-06,6.329644042986183,74.6190096445576,"['MTMR10', 'PLCB3', 'MTMR2', 'PLCB4', 'MTMR3', 'PIK3CA', 'PTEN', 'MTMR8', 'PIK3CD', 'PIP5K1B', 'MTM1']",0.0006657568802532806,0,0,11
5,ErbB signaling pathway WP673,7.759404198756184e-06,4.449424524125719,52.35462087595998,"['GSK3B', 'MAP2K4', 'PRKCB', 'GAB1', 'PIK3CD', 'PIK3R3', 'NRG1', 'BRAF', 'MAPK10', 'NRG3', 'PIK3CA', 'AKT3', 'ABL2', 'SOS1', 'SOS2']",0.0006657568802532806,0,0,15
6,Chemokine signaling pathway WP3929,1.3637221686035114e-05,3.599327102803738,40.322209143467646,"['VAV3', 'GSK3B', 'PRKCB', 'PXN', 'PIK3R3', 'PIK3CD', 'BRAF', 'NFKB1', 'NFKBIA', 'PLCB3', 'ADCY9', 'RAP1A', 'PLCB4', 'PIK3CA', 'AKT3', 'JAK2', 'SOS1', 'SOS2']",0.0009750613505515107,0,0,18
7,Ras signaling WP4223,3.862303795824447e-05,3.0584415584415585,31.07884820520312,"['PDGFRB', 'PRKCB', 'GAB1', 'PIK3R3', 'PIK3CD', 'RASAL2', 'STK4', 'NFKB1', 'IGF1R', 'MAPK10', 'AFDN', 'ZAP70', 'RAP1A', 'PIK3CA', 'AKT3', 'ABL2', 'RGL1', 'SOS1', 'RAPGEF5', 'SOS2']",0.0021040789772449084,0,0,20
8,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,4.203717606477576e-05,2.5339002528154446,25.534001829319305,"['ITGB1', 'GSK3B', 'LAMA5', 'IRS1', 'PTEN', 'LPAR2', 'PIK3CD', 'LAMC1', 'EFNA5', 'ACACA', 'IGF1R', 'GYS2', 'AKT3', 'ITGB8', 'ITGAV', 'JAK2', 'PDGFRB', 'VEGFC', 'TBC1D1', 'FGF14', 'COL5A1', 'PIK3CA', 'ITGA10', 'ITGA8', 'SOS1', 'FGF12', 'FGF10']",0.0021040789772449084,0,0,27
9,PI3K-Akt signaling pathway WP4172,4.4141517005137936e-05,2.477521966410855,24.844862285535715,"['ITGB1', 'GSK3B', 'LAMA5', 'IRS1', 'PTEN', 'PIK3R3', 'LPAR2', 'PIK3CD', 'LAMC1', 'EFNA5', 'IGF1R', 'GYS2', 'AKT3', 'ITGB8', 'ITGAV', 'JAK2', 'PDGFRB', 'VEGFC', 'NFKB1', 'FGF14', 'PIK3CA', 'ITGA10', 'ITGA8', 'PKN2', 'SOS1', 'FGF12', 'SOS2', 'FGF10']",0.0021040789772449084,0,0,28
10,T-Cell Receptor and Co-stimulatory Signaling WP2583,6.779142720313512e-05,8.731467882816727,83.81401343834193,"['NFKBIA', 'GSK3B', 'ZAP70', 'PTEN', 'DYRK1A', 'NFKB1', 'PDK1']",0.0027488313203908755,0,0,7
11,Integrin-mediated Cell Adhesion WP185,7.406566244417039e-05,3.7781620387469363,35.93243119731076,"['VASP', 'ITGB1', 'VAV3', 'PXN', 'BRAF', 'MAPK10', 'RAP1A', 'CAPN7', 'ITGA10', 'AKT3', 'ITGA8', 'ITGB8', 'ITGAV', 'SOS1']",0.0027488313203908755,0,0,14
12,Gastrin signaling pathway WP4659,7.689038658436015e-05,3.5555555555555554,33.68223893750828,"['ITGB1', 'GSK3B', 'IRS1', 'PXN', 'PIK3R3', 'FOS', 'PTGS2', 'NFKB1', 'NFKBIA', 'TJP1', 'PIK3CA', 'TCF4', 'PPARG', 'JAK2', 'SOS1']",0.0027488313203908755,0,0,15
13,Prolactin Signaling Pathway WP2037,0.00010069914463652156,4.187613843351548,38.5401732374968,"['ITGB1', 'NFKBIA', 'GSK3B', 'ZAP70', 'PIK3CA', 'IRS1', 'RPS6KA2', 'PXN', 'FOS', 'JAK2', 'SOS1', 'NFKB1']",0.0033230717730052114,0,0,12
14,Signaling of Hepatocyte Growth Factor Receptor WP313,0.00011009898697107776,6.529554655870445,59.51121464608525,"['ITGB1', 'RAP1A', 'PIK3CA', 'PXN', 'PTEN', 'GAB1', 'FOS', 'SOS1']",0.0033737475293280257,0,0,8
15,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.0001271430571385109,3.221196306704135,28.894767609181855,"['MAP2K4', 'GSK3B', 'IRS1', 'PIK3R3', 'PIK3CD', 'MAPK10', 'RPS6KA5', 'SESN3', 'PIK3CA', 'RPS6KA2', 'RICTOR', 'SOS1', 'MAP4K5', 'SOS2', 'MAP3K4', 'MAP4K3']",0.003636291434161412,0,0,16
16,Resistin as a regulator of inflammation WP4481,0.00015441439194024425,7.420367936925099,65.12018965489172,"['NFKBIA', 'PLCB3', 'PLCB4', 'PIK3CA', 'AKT3', 'PIK3CD', 'NFKB1']",0.004140235883897799,0,0,7
17,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.00016932587506868265,6.062406015037594,52.644026873819115,"['ITGB1', 'GSK3B', 'IRS1', 'PTEN', 'RICTOR', 'NFKB1', 'IGF1R', 'PDK1']",0.004272988259086168,0,0,8
18,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.00018931812790785226,5.165153295588079,44.276116257066825,"['MAPK10', 'MAP2K4', 'RPS6KA5', 'PIK3CA', 'RPS6KA2', 'AKT3', 'PIK3R3', 'EIF4G3', 'PDK1']",0.004468056038122004,0,0,9
19,PDGFR-beta pathway WP3972,0.0001978859317583172,7.066579062636881,60.262512816899154,"['PDGFRB', 'MAP2K4', 'PIK3CA', 'PRKCB', 'FOS', 'JAK2', 'SOS1']",0.004468056038122004,0,0,7
20,Hippo-Merlin Signaling Dysregulation WP4541,0.00022614734593829234,3.351563198521742,28.134106717704192,"['PDGFRB', 'ITGB1', 'CDH8', 'IGF1R', 'DCAF1', 'PLCB4', 'PRKAR2B', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGAV', 'NF2', 'TEAD1', 'CDH18']",0.0048508605703763705,0,0,14
21,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.00031260578896693544,4.776877470355731,38.55211264355342,"['NFKBIA', 'GSK3B', 'ZAP70', 'DLG1', 'PIK3CA', 'FOS', 'SOS1', 'NFKB1', 'PDK1']",0.0063860896888959665,0,0,9
22,Mesodermal commitment pathway WP2857,0.00034825613697625284,3.0447732878011764,24.24422751165154,"['HES7', 'VAV3', 'NCAPG2', 'ARID5B', 'PHF6', 'ACACA', 'PARP8', 'SESN1', 'UBR5', 'CCDC6', 'TCF4', 'ASCC3', 'JAK2', 'JARID2', 'TEAD1']",0.006790994671036931,0,0,15
23,Endometrial cancer WP4155,0.00044160101554197544,4.085143089100873,31.558154251299907,"['GSK3B', 'PIK3CA', 'AKT3', 'PTEN', 'PIK3CD', 'PIK3R3', 'BRAF', 'FOS', 'SOS1', 'SOS2']",0.008236818942065542,0,0,10
24,miRNA regulation of prostate cancer signaling pathways WP3981,0.00048020041866769775,5.934454664914586,45.34698998594109,"['PDGFRB', 'NFKBIA', 'GSK3B', 'PIK3CA', 'AKT3', 'SOS1', 'NFKB1']",0.008583582483685097,0,0,7
25,DNA damage response (only ATM dependent) WP710,0.0005264349887580449,3.2170645310334205,24.286851354476084,"['GSK3B', 'IRS1', 'PTEN', 'PIK3R3', 'PIK3CD', 'NFKB1', 'MAPK10', 'PIK3CA', 'AKT3', 'SOS1', 'SOS2', 'MAP3K4', 'PDK1']",0.009033624407088051,0,0,13
26,Disruption of postsynaptic signaling by CNV WP4875,0.0005858878077416299,5.705852623066815,42.46513623214822,"['TJP1', 'RYR2', 'CYFIP1', 'DLG1', 'NLGN4X', 'HOMER1', 'NRXN1']",0.009667148827736893,0,0,7
27,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.0006190041113745089,2.750514756348662,20.31914897953589,"['VAV3', 'CYFIP1', 'GSK3B', 'EGR2', 'IRS1', 'SORT1', 'FOS', 'ACACB', 'NFKB1', 'NFKBIA', 'MAPK10', 'GRIP1', 'DLG1', 'RPS6KA5', 'RAP1A', 'JAK2']",0.009835287547394976,0,0,16
28,Hepatitis B infection WP4666,0.0006962041797232661,2.8278038289320593,20.55775937567043,"['MAP2K4', 'EGR2', 'PRKCB', 'PIK3R3', 'PIK3CD', 'BRAF', 'FOS', 'NFKB1', 'MAPK10', 'PIK3CA', 'AKT3', 'TAB2', 'JAK2', 'SOS1', 'SOS2']",0.01066684261076004,0,0,15
29,Small cell lung cancer WP4658,0.0008206463070532708,3.2298573437813944,22.94948763458482,"['ITGB1', 'NFKBIA', 'LAMA5', 'PIK3CA', 'AKT3', 'PTEN', 'PIK3CD', 'PIK3R3', 'ITGAV', 'LAMC1', 'PTGS2', 'NFKB1']",0.012139905714684592,0,0,12
30,Neural Crest Cell Migration in Cancer WP4565,0.000852277610925823,5.297634691195795,37.44155367150886,"['TRIO', 'PIK3CA', 'SORT1', 'AKT3', 'PIK3R3', 'PIK3CD', 'FOS']",0.01218756983623927,0,0,7
31,Endoderm differentiation WP2853,0.0009174207672231155,2.8654866353805346,20.041054032041572,"['VAV3', 'NCAPG2', 'LAMC1', 'NR3C1', 'PHF6', 'ACACA', 'PARP8', 'RFX7', 'SESN1', 'SP4', 'UBR5', 'TCF4', 'ASCC3', 'JARID2']",0.012695919649636017,0,0,14
32,MET in type 1 papillary renal cell carcinoma WP4205,0.0009906383767488368,3.9787549407114624,27.521688495085122,"['RAP1A', 'PIK3CA', 'AKT3', 'GAB1', 'PIK3CD', 'PIK3R3', 'BRAF', 'SOS1', 'SOS2']",0.012806436565271792,0,0,9
33,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.0010171286998040669,5.114640445874303,35.2438192383121,"['PLCB3', 'PLCB4', 'PIK3CA', 'PRKCB', 'PIK3CD', 'NFKB1', 'PDK1']",0.012806436565271792,0,0,7
34,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.0010171286998040669,5.114640445874303,35.2438192383121,"['GABRQ', 'GABRB1', 'PIK3CA', 'GABRA3', 'PTEN', 'PIK3R3', 'JAK2']",0.012806436565271792,0,0,7
35,Glioblastoma signaling pathways WP2261,0.001044814171991871,3.338818645027364,22.91737150406976,"['PDGFRB', 'MAP2K4', 'PIK3CA', 'IRS1', 'PRKCB', 'AKT3', 'PTEN', 'GAB1', 'PIK3CD', 'BRAF', 'IGF1R']",0.012806436565271792,0,0,11
36,Nanoparticle-mediated activation of receptor signaling WP2643,0.001118269733689427,6.049118860142483,41.109646444262985,"['ITGB1', 'MAPK10', 'PXN', 'AKT3', 'PIK3CD', 'SOS1']",0.013326047659799004,0,0,6
37,Non-small cell lung cancer WP4255,0.0011762398982596391,3.538698328935796,23.87005055713416,"['PIK3CA', 'PRKCB', 'AKT3', 'PIK3CD', 'PIK3R3', 'BRAF', 'SOS1', 'STK4', 'SOS2', 'PDK1']",0.013638024766307709,0,0,10
38,Oncostatin M Signaling Pathway WP2374,0.0012764660414075453,3.8191304347826085,25.449386424810797,"['NFKBIA', 'IRS1', 'PRKCB', 'PXN', 'RICTOR', 'FOS', 'JAK2', 'SOS1', 'NFKB1']",0.014009624580439726,0,0,9
39,IL-4 signaling pathway WP395,0.0013062587021389022,4.240526315789474,28.15958893108973,"['NFKBIA', 'PIK3CA', 'IRS1', 'PIK3CD', 'FOS', 'JAK2', 'SOS1', 'NFKB1']",0.014009624580439726,0,0,8
40,Rett syndrome causing genes WP4312,0.0013062587021389022,4.240526315789474,28.15958893108973,"['TRRAP', 'SATB2', 'SCN8A', 'GABRA3', 'BRAF', 'TCF4', 'SMARCA1', 'SCN1A']",0.014009624580439726,0,0,8
41,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.001404339954709221,2.617725818039318,17.19371496425736,"['MAP2K4', 'GSK3B', 'PIK3R3', 'PIK3CD', 'PROX1', 'NR2C2', 'TJP1', 'ZEB2', 'ZEB1', 'FMNL2', 'PIK3CA', 'AKT3', 'PKP1', 'SOS1', 'SOS2']",0.014694191233420873,0,0,15
42,Toll-like Receptor Signaling Pathway WP75,0.0014657819178139954,3.4241212018044087,22.343645599350555,"['NFKBIA', 'MAPK10', 'MAP2K4', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CD', 'TAB2', 'FOS', 'NFKB1']",0.014971915303385808,0,0,10
43,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.0016610848015081814,5.52242382745635,35.34508304635095,"['GSK3B', 'PIK3CA', 'PTEN', 'PIK3R3', 'RICTOR', 'PDK1']",0.016254625036286906,0,0,6
44,"Relationship between inflammation, COX-2 and EGFR WP4483",0.0016671410293627594,7.0506771515945825,45.10067929898014,"['PIK3CA', 'AKT3', 'PIK3CD', 'BRAF', 'PTGS2']",0.016254625036286906,0,0,5
45,Pathways affected in adenoid cystic carcinoma WP3651,0.0020467137116575323,3.5353535353535355,21.889211554153732,"['KDM6B', 'PIK3CA', 'KAT6A', 'CHEK1', 'ATRX', 'PTEN', 'ERBIN', 'ARID5B', 'ARID4B']",0.019158985062146097,0,0,9
46,ESC Pluripotency Pathways WP3931,0.002054343386617064,2.865168539325843,17.72908702816119,"['PDGFRB', 'GSK3B', 'FGF14', 'AKT3', 'PTEN', 'GAB1', 'PIK3CD', 'BRAF', 'FOS', 'SOS1', 'FGF12', 'FGF10']",0.019158985062146097,0,0,12
47,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.0022505864438710976,4.361134729844632,26.587938977465036,"['ITGB1', 'MAPK10', 'ITGB8', 'NF2', 'MAP4K5', 'TEAD1', 'MAP4K3']",0.02044724052774416,0,0,7
48,Melanoma WP4685,0.0022878031359713745,3.4708587854832915,21.103388037381375,"['PIK3CA', 'AKT3', 'PTEN', 'PIK3CD', 'PIK3R3', 'BRAF', 'FOS', 'SOS1', 'SOS2']",0.02044724052774416,0,0,9
49,Regulation of toll-like receptor signaling pathway WP1449,0.0024274654185782053,2.8018489447060877,16.869673615303,"['NFKBIA', 'MAPK10', 'MAP2K4', 'PIK3CA', 'AKT3', 'PELI2', 'PIK3R3', 'PIK3CD', 'TAB2', 'FOS', 'ZMYND11', 'NFKB1']",0.021252707440205104,0,0,12
50,Neural Crest Cell Migration during Development WP4564,0.002822813884993371,4.884312537855845,28.67101746072434,"['TRIO', 'PIK3CA', 'AKT3', 'PIK3R3', 'PIK3CD', 'FOS']",0.024219743133243123,0,0,6
51,EPO Receptor Signaling WP581,0.0032323045212018994,5.874472113004223,33.68751234268625,"['PTPRU', 'IRS1', 'JAK2', 'SOS1', 'PDK1']",0.027189385090110096,0,0,5
52,MAPK Cascade WP422,0.0033199101483653353,4.703120443277924,26.844553453714383,"['MAPK10', 'MAP2K4', 'PLCB3', 'BRAF', 'SOS1', 'SOS2']",0.027389258724014015,0,0,6
53,Apoptosis WP254,0.0038520219458100303,3.1806324110671937,17.68163521170781,"['NFKBIA', 'MAPK10', 'HELLS', 'MAP2K4', 'CRADD', 'CASP6', 'CASP2', 'NFKB1', 'IGF1R']",0.03098194038945578,0,0,9
54,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.0038998246644070212,2.9467165054236295,16.344916904384693,"['GSK3B', 'TBC1D4', 'PIK3CA', 'NPY', 'AKT3', 'ITPR2', 'ITGAV', 'PPARG', 'SOS1', 'MAP4K5']",0.03098194038945578,0,0,10
55,Regulation of Actin Cytoskeleton WP51,0.004041107877956136,2.4003165910841107,13.228712162031334,"['PDGFRB', 'PXN', 'PIK3R3', 'PIK3CD', 'BRAF', 'GNA13', 'FGF14', 'PIK3CA', 'PIP5K1B', 'SOS1', 'FGF12', 'SOS2', 'FGF10', 'ARHGEF6']",0.031520641448057864,0,0,14
56,MAPK Signaling Pathway WP382,0.004169384112674911,2.0300483829895595,11.124638644380896,"['PDGFRB', 'MAP2K4', 'DUSP1', 'BRAF', 'FOS', 'STK4', 'NFKB1', 'MAPK10', 'RPS6KA5', 'RAP1A', 'FGF14', 'AKT3', 'RAPGEF2', 'TAB2', 'SOS1', 'FGF12', 'SOS2', 'MAP4K3', 'MAP3K4', 'FGF10']",0.031940460434598875,0,0,20
57,Aspirin and miRNAs WP4707,0.004392637268901173,12.665882352941177,68.74819905881297,"['PTGS2', 'NFKB1', 'PDK1']",0.03306037523436146,0,0,3
58,MAPK pathway in congenital thyroid cancer WP4928,0.004947279628484751,7.042757417102967,37.389417560955614,"['BRAF', 'FOS', 'SOS1', 'SOS2']",0.03619892355679649,0,0,4
59,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.004978406736249401,3.7055847568988174,19.64940186029635,"['NFKBIA', 'MAPK10', 'MAP2K4', 'RPS6KA5', 'TAB2', 'FOS', 'NFKB1']",0.03619892355679649,0,0,7
60,Pathways Regulating Hippo Signaling WP4540,0.0054924001303344235,2.790931815025691,14.525097452377599,"['PDGFRB', 'PLCB3', 'PLCB4', 'PRKCB', 'PRKAR2B', 'NF2', 'TEAD1', 'CDH8', 'CDH18', 'IGF1R']",0.038905522436951376,0,0,10
61,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.005605360381541534,3.6149802890932983,18.740173238060397,"['GSK3B', 'PIK3CA', 'HOMER1', 'AKT3', 'PTEN', 'PIK3CD', 'PIK3R3']",0.038905522436951376,0,0,7
62,Leptin signaling pathway WP2034,0.005622709536342623,2.9811017786561265,15.444914240804122,"['NCOA1', 'GSK3B', 'IRS1', 'PTEN', 'JAK2', 'SOS1', 'ACACB', 'ACACA', 'NFKB1']",0.038905522436951376,0,0,9
63,Development of ureteric collection system WP5053,0.005977007063019606,4.095250190500381,20.96700660003307,"['RET', 'ITGB1', 'GRIP1', 'FRAS1', 'GREB1L', 'ITGA8']",0.0400646254693033,0,0,6
64,G13 Signaling Pathway WP524,0.005977007063019606,4.095250190500381,20.96700660003307,"['GNA13', 'MAPK10', 'CYFIP1', 'PIK3CA', 'PIK3CD', 'MAP3K4']",0.0400646254693033,0,0,6
65,PTF1A related regulatory pathway WP4147,0.006368128519599938,10.554248366013072,53.36702544099115,"['KAT2B', 'PROX1', 'FGF10']",0.04202964822935959,0,0,3
66,Fragile X Syndrome  WP4549,0.006858989149905218,2.4261526832955402,12.087566258867287,"['CYFIP1', 'GRIP1', 'EPHA4', 'GRM5', 'HOMER1', 'KCND2', 'PTEN', 'GAB1', 'BRAF', 'SOS1', 'GRIP2', 'PDK1']",0.044583429474383915,0,0,12
67,Apoptosis Modulation by HSP70 WP384,0.007739317842282369,6.0359012715033655,29.3431823154422,"['MAPK10', 'CASP6', 'CASP2', 'NFKB1']",0.048811340814246304,0,0,4
68,PDGF Pathway WP2526,0.007770416869465762,3.8465759961822954,18.684479275938237,"['PDGFRB', 'NFKBIA', 'MAP2K4', 'FOS', 'SOS1', 'NFKB1']",0.048811340814246304,0,0,6
69,Breast cancer pathway WP4262,0.007938825232442645,2.281528104646708,11.033447030986524,"['NCOA1', 'GSK3B', 'PTEN', 'PIK3R3', 'PIK3CD', 'BRAF', 'FOS', 'IGF1R', 'PIK3CA', 'AKT3', 'SOS1', 'SOS2', 'FGF10']",0.048811340814246304,0,0,13
70,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.007964554445215015,2.80504533829342,13.556094853758598,"['GSK3B', 'MAP2K4', 'PIK3CA', 'PRKCB', 'PIK3CD', 'PIK3R3', 'NRG1', 'NFKB1', 'IGF1R']",0.048811340814246304,0,0,9
71,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.008124367368622829,3.02593984962406,14.563507824195037,"['GNA13', 'RAP1A', 'PIK3CA', 'PDE4D', 'BRAF', 'FOS', 'JAK2', 'IGF1R']",0.04908948733998864,0,0,8
72,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.009456904513067714,5.633158813263526,26.256210506342317,"['RPS6KA5', 'RAP1A', 'BRAF', 'NR3C1']",0.05634738939036179,0,0,4
73,IL-6 signaling pathway WP364,0.009921744169805067,3.6263217097862768,16.728318324531422,"['NCOA1', 'GSK3B', 'MAP2K4', 'GAB1', 'JAK2', 'SOS1']",0.057519300660086134,0,0,6
74,Splicing factor NOVA regulated synaptic proteins WP4148,0.009921744169805067,3.6263217097862768,16.728318324531422,"['PLCB4', 'CADM1', 'EPB41', 'GRIK2', 'EFNA5', 'NEO1']",0.057519300660086134,0,0,6
75,Corticotropin-releasing hormone signaling pathway WP2355,0.010159643784835687,2.6860212659355343,12.327043074448454,"['NFKBIA', 'GSK3B', 'NCOA2', 'PRKCB', 'BRAF', 'TCF4', 'FOS', 'ACACA', 'NFKB1']",0.058113162449260125,0,0,9
76,Genes controlling nephrogenesis WP4823,0.010539012394751829,4.2277850589777195,19.24771629646939,"['RET', 'ITGB1', 'PDGFRB', 'ITGA8', 'CD2AP']",0.059489951544059665,0,0,5
77,EGF/EGFR signaling pathway WP437,0.011014241656358722,2.108678066858551,9.50711454831407,"['VAV3', 'PRKCB', 'PTEN', 'GAB1', 'BRAF', 'FOS', 'RPS6KA5', 'RAP1A', 'RPS6KA2', 'RICTOR', 'JAK2', 'SOS1', 'SOS2', 'MAP3K4']",0.061365060656855736,0,0,14
78,Hippo-Yap signaling pathway WP4537,0.011404350384511963,5.2807591623036645,23.624851136179146,"['NF2', 'TNIK', 'TEAD1', 'MAP4K3']",0.06192995335386876,0,0,4
79,Vitamin D in inflammatory diseases WP4482,0.011404350384511963,5.2807591623036645,23.624851136179146,"['NFKBIA', 'DUSP1', 'NR3C1', 'NFKB1']",0.06192995335386876,0,0,4
80,Pathways in clear cell renal cell carcinoma WP4018,0.012781479370446026,2.5766477940390984,11.233561039494969,"['PDGFRB', 'PBRM1', 'ZEB1', 'PTEN', 'PLOD2', 'RAPGEF5', 'ACACB', 'ACACA', 'PFKP']",0.06854068312401682,0,0,9
81,Circadian rhythm related genes WP3594,0.013004328133220238,2.0039339497356488,8.702029157893891,"['NCOA2', 'GSK3B', 'HOMER1', 'KCND2', 'DYRK1A', 'PTEN', 'RORA', 'PROX1', 'MAPK10', 'PER3', 'PSPC1', 'PPARG', 'DRD1', 'TOP1', 'CLOCK']",0.06887477492779608,0,0,15
82,Head and Neck Squamous Cell Carcinoma WP4674,0.014829623315663842,2.6885547201336677,11.321849468441116,"['PIK3CA', 'SESN1', 'AKT3', 'PTEN', 'GAB1', 'RICTOR', 'NFKB1', 'IGF1R']",0.07693737579878422,0,0,8
83,Cancer immunotherapy by CTLA4 blockade WP4582,0.015064660995566142,7.034858387799564,29.51407027204958,"['PIK3CA', 'PIK3CD', 'PIK3R3']",0.07693737579878422,0,0,3
84,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.015064660995566142,7.034858387799564,29.51407027204958,"['ZEB1', 'JAK2', 'NFKB1']",0.07693737579878422,0,0,3
85,Alpha 6 Beta 4 signaling pathway WP244,0.015702957853125626,3.774105972664295,15.677282146788096,"['LAMA5', 'IRS1', 'GAB1', 'LAMC1', 'SOS1']",0.0781398099461105,0,0,5
86,Nuclear receptors WP170,0.015702957853125626,3.774105972664295,15.677282146788096,"['RORA', 'ROR1', 'PPARG', 'NR2C2', 'NR3C1']",0.0781398099461105,0,0,5
87,Estrogen signaling pathway WP712,0.01602867896330472,4.693426410703897,19.399694797915256,"['PIK3CA', 'BRAF', 'FOS', 'NFKB1']",0.0781398099461105,0,0,4
88,PKC-gamma calcium signaling pathway in ataxia WP4760,0.01602867896330472,4.693426410703897,19.399694797915256,"['PLCB3', 'PLCB4', 'CA8', 'PDK1']",0.0781398099461105,0,0,4
89,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.018722658044711713,4.446128410030312,17.68679142103862,"['TGFBR3', 'NR2C2', 'LTBP1', 'FBN1']",0.08926074541430164,0,0,4
90,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.018862761151910715,3.094488188976378,12.28686838355317,"['TGFBR3', 'ZEB2', 'FOS', 'LTBP1', 'NFKB1', 'FBN1']",0.08926074541430164,0,0,6
91,Development and heterogeneity of the ILC family WP3893,0.01893409751212459,6.330980392156863,25.113675288548436,"['IL15', 'ZBTB16', 'RORA']",0.08926074541430164,0,0,3
92,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.0199475008922644,3.5220620358235037,13.787645121868408,"['MAPK10', 'MAP2K4', 'RPS6KA2', 'FOS', 'MAP3K4']",0.09301606394327638,0,0,5
93,Apoptosis Modulation and Signaling WP1772,0.021611635095787476,2.490092879256966,9.548319531904403,"['NFKBIA', 'TNFRSF6B', 'CRADD', 'CASP6', 'CASP2', 'BIRC6', 'FOS', 'NFKB1']",0.09931678533958178,0,0,8
94,AMP-activated protein kinase (AMPK) signaling WP1403,0.021761719864616988,2.692462071437104,10.305675423357608,"['GYS2', 'PIK3CA', 'PIK3CD', 'PIK3R3', 'CPT1B', 'ACACB', 'ACACA']",0.09931678533958178,0,0,7
95,Leptin Insulin Overlap WP3935,0.02330017934438496,5.755080213903743,21.635039790994245,"['IRS1', 'PIK3R3', 'JAK2']",0.10412267644522029,0,0,3
96,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.02330017934438496,5.755080213903743,21.635039790994245,"['ITGB1', 'ZEB2', 'NRG3']",0.10412267644522029,0,0,3
97,Adipogenesis WP236,0.024873466404723422,2.161434494642184,7.984238840523722,"['NCOA1', 'NCOA2', 'MBNL1', 'EGR2', 'IRS1', 'SPOCK1', 'RORA', 'PPARG', 'NR3C1', 'LPIN3']",0.10909683964396054,0,0,10
98,Wnt Signaling Pathway WP363,0.02492188877647583,2.8829634931997137,10.643926570644494,"['GSK3B', 'PRKCB', 'PPARG', 'ROR1', 'PIP5K1B', 'TCF4']",0.10909683964396054,0,0,6
99,Pilocytic astrocytoma WP2253,0.027317594469219275,10.54177545691906,37.9527561475513,"['BRAF', 'SOS1']",0.11659398891502963,0,0,2
100,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.027317594469219275,10.54177545691906,37.9527561475513,"['PTEN', 'IGF1R']",0.11659398891502963,0,0,2
101,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.027449866854121194,2.5527210113734196,9.178037709751896,"['CDK8', 'SEC24B', 'PIK3CA', 'PPARG', 'SEC24D', 'LSS', 'ACACA']",0.11659398891502963,0,0,7
102,Overview of nanoparticle effects WP3287,0.028163477375539894,5.27516339869281,18.830905182906708,"['AKT3', 'PIK3CD', 'PTGS2']",0.11719316279183331,0,0,3
103,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.028163477375539894,5.27516339869281,18.830905182906708,"['GSK3B', 'TNKS', 'TCF4']",0.11719316279183331,0,0,3
104,White fat cell differentiation WP4149,0.028410463707111106,3.8391242265587815,13.671112776056372,"['EGR2', 'RORA', 'PPARG', 'NR3C1']",0.11719316279183331,0,0,4
105,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.03175707566581838,2.467323696890057,8.5113778339352,"['ITGB1', 'RYR2', 'ITGA10', 'ITGA8', 'ITGB8', 'ITGAV', 'SLC8A1']",0.12906201078076307,0,0,7
106,IL17 signaling pathway WP2112,0.03219029173319732,3.6719781470521284,12.61724875309693,"['GSK3B', 'PIK3CA', 'JAK2', 'NFKB1']",0.12906201078076307,0,0,4
107,Lipid Metabolism Pathway WP3965,0.03219029173319732,3.6719781470521284,12.61724875309693,"['ACSS2', 'PRKAR2B', 'AKT3', 'ACACA']",0.12906201078076307,0,0,4
108,Overview of interferons-mediated signaling pathway WP4558,0.033521070976718206,4.8690799396681745,16.533355591110453,"['PIK3CA', 'IFNE', 'JAK2']",0.13118774886429807,0,0,3
109,DNA Replication WP466,0.033637884324178996,3.017974162141921,10.237277209995915,"['PRIM2', 'ORC1', 'POLD1', 'MCM10', 'POLE']",0.13118774886429807,0,0,5
110,Nephrotic syndrome WP4758,0.033637884324178996,3.017974162141921,10.237277209995915,"['CUBN', 'ANLN', 'TTC21B', 'MYH9', 'CD2AP']",0.13118774886429807,0,0,5
111,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.0362503080948262,3.518760907504363,11.672811592192566,"['ITGB1', 'LAMA5', 'EDA', 'NFKB1']",0.13964446747134637,0,0,4
112,Insulin signaling in adipocytes (diabetic condition) WP3635,0.03710832002735079,8.43289817232376,27.777241982975585,"['TBC1D4', 'IRS1']",0.13964446747134637,0,0,2
113,Insulin signaling in adipocytes (normal condition) WP3634,0.03710832002735079,8.43289817232376,27.777241982975585,"['TBC1D4', 'IRS1']",0.13964446747134637,0,0,2
114,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.03710832002735079,8.43289817232376,27.777241982975585,"['NFKBIA', 'NFKB1']",0.13964446747134637,0,0,2
115,Wnt signaling WP428,0.03781180620793388,2.093080832211267,6.855119971390206,"['GSK3B', 'PLCB3', 'SFRP2', 'PLCB4', 'PRKCB', 'PRICKLE2', 'ROR1', 'CXXC4', 'DKK2']",0.14105447707133595,0,0,9
116,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.03936697185713077,4.5210084033613445,14.624684987213545,"['TJP1', 'PXN', 'ITGAV']",0.145589921781975,0,0,3
117,Pancreatic adenocarcinoma pathway WP4263,0.041219292201679726,2.1695006747638326,6.918209785821038,"['MAPK10', 'PIK3CA', 'AKT3', 'PIK3CD', 'PIK3R3', 'BRAF', 'NFKB1', 'ARHGEF6']",0.15113740473949233,0,0,8
118,VEGFA-VEGFR2 Signaling Pathway WP3888,0.04355510187784203,1.47440790655885,4.620393978110521,"['ITGB1', 'GSK3B', 'EPB41', 'PXN', 'PTGS2', 'ACACB', 'SLC8A1', 'ACACA', 'RAP1A', 'RPS6KA5', 'RICTOR', 'ITGAV', 'ASCC3', 'MAP2K4', 'PRKCB', 'EIF2AK3', 'GAB1', 'ADAM10', 'PDE4DIP', 'NFKB1', 'NFKBIA', 'INPP4B', 'AFDN', 'PLCB3', 'PIK3CA', 'MYH9']",0.1563354169462185,0,0,26
119,3q29 copy number variation syndrome WP4906,0.04374612853894477,2.486181874324533,7.78013862014268,"['DLG1', 'CEP350', 'PXN', 'ADAM10', 'PIK3R3', 'NF2']",0.1563354169462185,0,0,6
120,Regulation of Microtubule Cytoskeleton WP2038,0.04409460477970265,2.7791956956611714,8.675031038099721,"['GSK3B', 'CLIP1', 'TRIO', 'PIK3CA', 'PTEN']",0.1563354169462185,0,0,5
121,TGF-beta Receptor Signaling WP560,0.04409460477970265,2.7791956956611714,8.675031038099721,"['TGFBR3', 'ZEB2', 'FOS', 'LTBP1', 'NFKB1']",0.1563354169462185,0,0,5
122,Transcription factor regulation in adipogenesis WP3599,0.045692511833169185,4.219346405228758,13.020147107934315,"['IRS1', 'PPARG', 'NR3C1']",0.1606728489871277,0,0,3
123,Canonical NF-KB pathway WP4562,0.048013567788840424,7.026979982593559,21.33582007638893,"['NFKBIA', 'NFKB1']",0.16746195594644342,0,0,2
124,B Cell Receptor Signaling Pathway WP23,0.0515902474466603,2.0631578947368423,6.116071946911663,"['NFKBIA', 'GSK3B', 'PRKCB', 'GAB1', 'PIP5K1B', 'BRAF', 'SOS1', 'NFKB1']",0.17848561415013925,0,0,8
125,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.05248669712477756,3.9553921568627453,11.657314082490021,"['ACACB', 'ACACA', 'PDK1']",0.17870470687721884,0,0,3
126,Inflammatory Response Pathway WP453,0.05248669712477756,3.9553921568627453,11.657314082490021,"['LAMA5', 'ZAP70', 'LAMC1']",0.17870470687721884,0,0,3
127,Globo Sphingolipid Metabolism WP1424,0.05973653164024669,3.722491349480969,10.48927902798633,"['ST8SIA1', 'B3GALT5', 'ST6GALNAC3']",0.19310557492695718,0,0,3
128,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.05973653164024669,3.722491349480969,10.48927902798633,"['SGPL1', 'GALNT16', 'ST6GALNAC3']",0.19310557492695718,0,0,3
129,Biotin Metabolism (including IEMs) WP5031,0.05991228322152974,6.022752704214845,16.953288385967813,"['ACACB', 'ACACA']",0.19310557492695718,0,0,2
130,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.05991228322152974,6.022752704214845,16.953288385967813,"['HES7', 'EPHA4']",0.19310557492695718,0,0,2
131,Supression of HMGB1 mediated inflammation by THBD WP4479,0.05991228322152974,6.022752704214845,16.953288385967813,"['NFKBIA', 'NFKB1']",0.19310557492695718,0,0,2
132,Alzheimer's disease WP2059,0.05998233046497129,2.1135348226018396,5.946864031446786,"['GSK3B', 'PLCB3', 'PLCB4', 'EIF2AK3', 'ADAM10', 'ITPR2', 'IDE']",0.19310557492695718,0,0,7
133,TGF-beta Signaling Pathway WP366,0.06070606386312759,1.8239923573833137,5.110300704693983,"['ITGB1', 'TGFBR3', 'MAP2K4', 'ZEB2', 'ZEB1', 'SMURF2', 'WWP1', 'FOS', 'SOS1', 'PDK1']",0.19310557492695718,0,0,10
134,BDNF-TrkB Signaling WP3676,0.06076748861337814,2.9111753024011553,8.15332971682048,"['HOMER1', 'GAB1', 'BRAF', 'SOS1']",0.19310557492695718,0,0,4
135,Melatonin metabolism and effects WP3298,0.06076748861337814,2.9111753024011553,8.15332971682048,"['GSK3B', 'PER3', 'CLOCK', 'NFKB1']",0.19310557492695718,0,0,4
136,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.06549078421443613,2.223649675369526,6.061326228911339,"['ITGB1', 'NFKBIA', 'PIK3CA', 'PXN', 'SOS1', 'NFKB1']",0.20658490020583162,0,0,6
137,Microglia Pathogen Phagocytosis Pathway WP3937,0.06650429021695735,2.8139616055846424,7.6272114686401675,"['VAV3', 'PIK3CA', 'PIK3R3', 'PIK3CD']",0.2082506606063847,0,0,4
138,Copper homeostasis WP3286,0.07024408749111778,2.399320862623615,6.372066292654493,"['GSK3B', 'ATP7B', 'PIK3CA', 'PTEN', 'ADAM10']",0.2183674893745618,0,0,5
139,Gene regulatory network modelling somitogenesis  WP2854,0.0726920796781293,5.26958224543081,13.814330243469772,"['HES7', 'EPHA4']",0.2227493012994105,0,0,2
140,TCA cycle in senescence WP5050,0.0726920796781293,5.26958224543081,13.814330243469772,"['BRAF', 'PDK1']",0.2227493012994105,0,0,2
141,7q11.23 copy number variation syndrome WP4932,0.07348333306718462,1.9000591366055588,4.96047804072815,"['GRIP1', 'CLIP2', 'ELN', 'EIF2AK3', 'NRG1', 'ACACB', 'ACACA', 'FBN1']",0.22357694954483828,0,0,8
142,Fatty Acid Biosynthesis WP357,0.07554289297261568,3.3302373581011353,8.602185144076385,"['ACSS2', 'ACACB', 'ACACA']",0.22662867891784705,0,0,3
143,NRF2-ARE regulation WP4357,0.07554289297261568,3.3302373581011353,8.602185144076385,"['GSK3B', 'MAF', 'PIK3CA']",0.22662867891784705,0,0,3
144,Regulatory circuits of the STAT3 signaling pathway WP4538,0.07835959812740283,2.1120734908136485,5.378282812591071,"['PTPRT', 'PDGFRB', 'MAPK10', 'PRKCB', 'RICTOR', 'JAK2']",0.23222283781006234,0,0,6
145,Retinoblastoma gene in cancer WP2446,0.07849023655584858,1.9720192728865529,5.0183572502673,"['ANLN', 'TFDP2', 'ORC1', 'CHEK1', 'CCDC6', 'SKP2', 'POLE']",0.23222283781006234,0,0,7
146,Interferon type I signaling pathways WP585,0.08050605488132134,2.2947176477292155,5.781364148200072,"['ZAP70', 'RPS6KA5', 'RAP1A', 'IRS1', 'PIK3CD']",0.23655546263073188,0,0,5
147,TLR4 Signaling and Tolerance WP3851,0.08406593571003837,3.163529411764706,7.833385498113649,"['NFKBIA', 'TAB2', 'NFKB1']",0.24003743087417853,0,0,3
148,IL-5 signaling pathway WP127,0.08531880299082555,2.5576709503411075,6.295350032073996,"['GSK3B', 'FOS', 'JAK2', 'SOS1']",0.24003743087417853,0,0,4
149,Vitamin D-sensitive calcium signaling in depression WP4698,0.08531880299082555,2.5576709503411075,6.295350032073996,"['KDM6B', 'GRM5', 'ITPR2', 'SLC8A1']",0.24003743087417853,0,0,4
150,"NAD metabolism, sirtuins and aging WP3630",0.08624870260400425,4.6837829997098925,11.477705159788409,"['PPARG', 'NFKB1']",0.24003743087417853,0,0,2
151,Neuroinflammation WP4919,0.08624870260400425,4.6837829997098925,11.477705159788409,"['NFKBIA', 'FOS']",0.24003743087417853,0,0,2
152,Osteoblast Signaling WP322,0.08624870260400425,4.6837829997098925,11.477705159788409,"['PDGFRB', 'ITGAV']",0.24003743087417853,0,0,2
153,Osteopontin Signaling WP1434,0.08624870260400425,4.6837829997098925,11.477705159788409,"['ITGAV', 'NFKB1']",0.24003743087417853,0,0,2
154,Transcriptional cascade regulating adipogenesis WP4211,0.08624870260400425,4.6837829997098925,11.477705159788409,"['EGR2', 'PPARG']",0.24003743087417853,0,0,2
155,Androgen receptor signaling pathway WP138,0.08672681068880576,1.9205590729900848,4.695751968145603,"['NCOA1', 'GSK3B', 'NCOA2', 'KAT2B', 'PTEN', 'NR2C2', 'PLPP1']",0.24003743087417853,0,0,7
156,16p11.2 proximal deletion syndrome WP4949,0.08767303493057874,2.0436880873761747,4.974624752798413,"['PPP4R4', 'PTEN', 'CCDC6', 'PPARG', 'NR3C1', 'NFKB1']",0.24094427964257775,0,0,6
157,Thermogenesis WP4321,0.08817774336569861,1.8178834182229768,4.41454934825337,"['ADCY9', 'SMARCD3', 'RPS6KA2', 'PPARG', 'SOS1', 'CPT1B', 'ARID1B', 'SOS2']",0.24094427964257775,0,0,8
158,Myometrial relaxation and contraction pathways WP289,0.09052647557337806,1.678184026468987,4.031187537636441,"['RYR2', 'PLCB3', 'ADCY9', 'PRKCB', 'PRKAR2B', 'PDE4D', 'ITPR2', 'FOS', 'SLC8A1', 'NFKB1']",0.2454293541788303,0,0,10
159,IL-1 signaling pathway WP195,0.09152091315231689,2.198831367409349,5.257818682341288,"['NFKBIA', 'MAP2K4', 'PELI2', 'TAB2', 'NFKB1']",0.2454293541788303,0,0,5
160,ATM Signaling Pathway WP2516,0.09210751986664727,2.482291345857715,5.919765150102306,"['NFKBIA', 'CRADD', 'CHEK1', 'CASP2']",0.2454293541788303,0,0,4
161,Prostaglandin Synthesis and Regulation WP98,0.09210751986664727,2.482291345857715,5.919765150102306,"['HSD11B2', 'PPARG', 'PTGS2', 'PTGES']",0.2454293541788303,0,0,4
162,miRNAs involvement in the immune response in sepsis WP4329,0.09297812331826037,3.0126984126984127,7.156336835742879,"['NFKBIA', 'TAB2', 'NFKB1']",0.2462198450835414,0,0,3
163,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.09756450740622415,1.9795767716535433,4.606953225971092,"['MAPK10', 'GSK3B', 'AKT3', 'BRAF', 'FOS', 'PTGS2']",0.25678020660901935,0,0,6
164,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.09914460804247313,2.4112191473448017,5.572751359479989,"['NFKBIA', 'PIK3CA', 'JAK2', 'NFKB1']",0.2581334729872912,0,0,4
165,G Protein Signaling Pathways WP35,0.09996480999690505,1.8481931668856768,4.256272528738133,"['GNA13', 'PLCB3', 'ADCY9', 'PRKCB', 'PRKAR2B', 'PDE4D', 'AKAP3']",0.2581334729872912,0,0,7
166,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.1004855244495982,4.215143603133159,9.685310795025092,"['NFKBIA', 'NFKB1']",0.2581334729872912,0,0,2
167,Serotonin and anxiety-related events WP3944,0.1004855244495982,4.215143603133159,9.685310795025092,"['PRKCB', 'FOS']",0.2581334729872912,0,0,2
168,Cell migration and invasion through p75NTR WP4561,0.10226036278218299,2.875579322638146,6.556991273042367,"['TRIO', 'AKT3', 'EFNA5']",0.26060034429222384,0,0,3
169,Endochondral Ossification with Skeletal Dysplasias WP4808,0.10326820170088125,2.1106159895150722,4.791996943760081,"['ACAN', 'COL10A1', 'SLC38A2', 'IGF1R', 'SOX5']",0.26060034429222384,0,0,5
170,Endochondral Ossification WP474,0.10326820170088125,2.1106159895150722,4.791996943760081,"['ACAN', 'COL10A1', 'SLC38A2', 'IGF1R', 'SOX5']",0.26060034429222384,0,0,5
171,Common Pathways Underlying Drug Addiction WP2636,0.10642313708481381,2.3440954043048285,5.251552582699097,"['GRM5', 'RAP1A', 'PRKCB', 'DRD1']",0.26699137900225217,0,0,4
172,Nephrogenesis WP5052,0.11531306858194723,3.8317113695703773,8.276897025629536,"['GREB1L', 'RSPO3']",0.28761224663753115,0,0,2
173,Oxidative Stress WP408,0.12185580430795588,2.6356209150326797,5.547762914282002,"['MAPK10', 'FOS', 'NFKB1']",0.30129967316950323,0,0,3
174,AGE/RAGE pathway WP2324,0.12220546184497333,1.990776230866243,4.184714236501599,"['NFKBIA', 'IRS1', 'PRKCB', 'JAK2', 'NFKB1']",0.30129967316950323,0,0,5
175,T-cell receptor (TCR) signaling pathway WP69,0.1247376894082444,1.8355585986534293,3.8207927411562737,"['VAV3', 'NFKBIA', 'ZAP70', 'FOS', 'SOS1', 'NFKB1']",0.3057855357493534,0,0,6
176,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.12885365981119226,1.9537886510363573,4.003465221584725,"['PLCB3', 'PLCB4', 'PRKCB', 'SP3', 'NFKB1']",0.30965874298728835,0,0,5
177,IL-3 signaling pathway WP286,0.12963147339242226,2.163377634581823,4.4199096054904565,"['PIK3CD', 'FOS', 'JAK2', 'SOS1']",0.30965874298728835,0,0,4
178,FOXA2 pathway WP5066,0.13064856056107038,3.512184508268059,7.148153517142035,"['IRS1', 'ACACA']",0.30965874298728835,0,0,2
179,Galanin receptor pathway WP4970,0.13064856056107038,3.512184508268059,7.148153517142035,"['PPARG', 'FOS']",0.30965874298728835,0,0,2
180,miR-509-3p alteration of YAP1/ECM axis WP3967,0.13064856056107038,3.512184508268059,7.148153517142035,"['COL5A1', 'TEAD1']",0.30965874298728835,0,0,2
181,Phytochemical activity on NRF2 transcriptional activation WP3,0.13064856056107038,3.512184508268059,7.148153517142035,"['MAF', 'PIK3CA']",0.30965874298728835,0,0,2
182,Ebola Virus Pathway on Host WP4217,0.1317630185023101,1.6403679100664281,3.324616128051774,"['ITGB1', 'PIK3CA', 'PIK3R3', 'PIK3CD', 'ITGAV', 'TOP1', 'NFKB1', 'IGF1R']",0.31058425789830235,0,0,8
183,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.1377979956827379,2.1091623036649216,4.180288956427143,"['ADCY9', 'TMEM43', 'SOS1', 'SOS2']",0.3230346456169102,0,0,4
184,Cell cycle WP179,0.1416065645907669,1.608922305764411,3.144964837421674,"['GSK3B', 'STAG1', 'STAG2', 'ORC1', 'TFDP2', 'CDC27', 'CHEK1', 'SKP2']",0.33015878374695107,0,0,8
185,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.14263161922095216,1.7587489063867017,3.4251460165901326,"['GSK3B', 'CDK8', 'SFRP2', 'ROR1', 'CXXC4', 'DKK2']",0.3307511602475053,0,0,6
186,Blood Clotting Cascade WP272,0.14641550546044924,3.2418156256276363,6.228522313304554,"['F11', 'KLKB1']",0.33410772256666343,0,0,2
187,Hypertrophy Model WP516,0.14641550546044924,3.2418156256276363,6.228522313304554,"['ZEB1', 'ADAM10']",0.33410772256666343,0,0,2
188,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.14641550546044924,3.2418156256276363,6.228522313304554,"['GSK3B', 'MAP3K4']",0.33410772256666343,0,0,2
189,GABA receptor Signaling WP4159,0.1535209440452741,2.3423384168482206,4.389350772524918,"['GABRQ', 'GABRB1', 'GABRA3']",0.3466341315548558,0,0,3
190,Sleep regulation WP3591,0.1535209440452741,2.3423384168482206,4.389350772524918,"['PER3', 'DRD1', 'FOS']",0.3466341315548558,0,0,3
191,Cancer immunotherapy by PD-1 blockade WP4585,0.1625432894743914,3.010070869078702,5.468729612647561,"['ZAP70', 'NFKB1']",0.3613008869663933,0,0,2
192,Serotonin and anxiety WP3947,0.1625432894743914,3.010070869078702,5.468729612647561,"['PRKCB', 'FOS']",0.3613008869663933,0,0,2
193,Transcription co-factors SKI and SKIL protein partners WP4533,0.1625432894743914,3.010070869078702,5.468729612647561,"['SATB2', 'TEAD1']",0.3613008869663933,0,0,2
194,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.16459958680337375,2.2585434173669467,4.074953248449653,"['NFKBIA', 'FOS', 'NFKB1']",0.3639856842198317,0,0,3
195,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.16956350687705438,7.019122120817036,12.455626987486095,['NFKB1'],0.37113645127681805,0,0,1
196,Nanomaterial-induced inflammasome activation WP3890,0.16956350687705438,7.019122120817036,12.455626987486095,['NFKB1'],0.37113645127681805,0,0,1
197,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.17195348525507412,1.7577544779379641,3.094581729203847,"['ITGB1', 'LAMA5', 'MYH9', 'ITGAV', 'CD2AP']",0.37445708210368933,0,0,5
198,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.1759059146844721,2.18052738336714,3.7893335755115016,"['NFKBIA', 'NELFA', 'NFKB1']",0.38112948181635614,0,0,3
199,BMP Signaling Pathway in Eyelid Development WP3927,0.1789668048758949,2.809225413402959,4.833426656872108,"['DKK2', 'FGF10']",0.38529587564735257,0,0,2
200,Acute viral myocarditis WP4298,0.17962511685191263,1.728831403218529,2.96820173712762,"['GSK3B', 'CASP6', 'CASP2', 'ABL2', 'SOS1']",0.38529587564735257,0,0,5
201,Osteoblast differentiation WP4787,0.1871525873375712,1.5386279018834867,2.578480365886127,"['MAPK10', 'PIK3CA', 'PRKCB', 'PIK3R3', 'PIK3CD', 'PPARG', 'FGF10']",0.3994450744667565,0,0,7
202,15q13.3 copy number variation syndrome WP4942,0.19562609668514497,2.633485639686684,4.296663789446798,"['KAT2B', 'MTMR10']",0.4134167264922522,0,0,2
203,IL1 and megakaryocytes in obesity WP2865,0.19562609668514497,2.633485639686684,4.296663789446798,"['PIK3CA', 'NFKB1']",0.4134167264922522,0,0,2
204,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.2000710847121675,1.794251977275259,2.887099550563255,"['VAV3', 'HELLS', 'NRG1', 'NFKB1']",0.41464007411362247,0,0,4
205,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.2000710847121675,1.794251977275259,2.887099550563255,"['NFKBIA', 'MAPK10', 'IFNE', 'NFKB1']",0.41464007411362247,0,0,4
206,Phosphodiesterases in neuronal function WP4222,0.2000710847121675,1.794251977275259,2.887099550563255,"['PDE11A', 'ADCY9', 'PDE4D', 'DRD1']",0.41464007411362247,0,0,4
207,RANKL/RANK signaling pathway WP2018,0.2000710847121675,1.794251977275259,2.887099550563255,"['NFKBIA', 'TAB2', 'FOS', 'NFKB1']",0.41464007411362247,0,0,4
208,Senescence and Autophagy in Cancer WP615,0.20258949158092493,1.5624574705939536,2.4945782804351455,"['UVRAG', 'GSK3B', 'PTEN', 'COL10A1', 'BRAF', 'IGF1R']",0.41784082638565767,0,0,6
209,Mitochondrial fatty acid synthesis pathway WP4317,0.20726148290095905,5.264015645371577,8.284371381851184,['ACACA'],0.4181097564544121,0,0,1
210,Integrated breast cancer pathway WP1984,0.20773066268372534,1.4070267896354853,2.2111607918120044,"['FER', 'RAP1A', 'IRS1', 'RALGAPA1', 'ZMYND8', 'CHEK1', 'PTEN', 'BRAF', 'NFKB1']",0.4181097564544121,0,0,9
211,Cardiac Hypertrophic Response WP2795,0.20958363240144962,1.756762652705061,2.7451742740834675,"['GSK3B', 'MAP2K4', 'NRG1', 'NFKB1']",0.4181097564544121,0,0,4
212,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.2115080194755231,1.6220385119467688,2.5198244425411307,"['GSK3B', 'SFRP2', 'ROR1', 'CXXC4', 'DKK2']",0.4181097564544121,0,0,5
213,Ebstein-Barr virus LMP1 signaling WP262,0.21246603008639123,2.4784211334664414,3.8390078194105817,"['NFKBIA', 'NFKB1']",0.4181097564544121,0,0,2
214,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.21246603008639123,2.4784211334664414,3.8390078194105817,"['PTEN', 'ZFX']",0.4181097564544121,0,0,2
215,Imatinib and Chronic Myeloid Leukemia WP3640,0.21246603008639123,2.4784211334664414,3.8390078194105817,"['PDGFRB', 'SKP2']",0.4181097564544121,0,0,2
216,miRNA targets in ECM and membrane receptors WP2911,0.21246603008639123,2.4784211334664414,3.8390078194105817,"['COL5A1', 'LAMC1']",0.4181097564544121,0,0,2
217,RAS and bradykinin pathways in COVID-19 WP4969,0.21246603008639123,2.4784211334664414,3.8390078194105817,"['KLKB1', 'NFKB1']",0.4181097564544121,0,0,2
218,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.21246603008639123,2.4784211334664414,3.8390078194105817,"['NFKBIA', 'NFKB1']",0.4181097564544121,0,0,2
219,Modulators of TCR signaling and T cell activation WP5072,0.2192214064198537,1.7208035046479324,2.6116171406077515,"['GNA13', 'NFKBIA', 'ZAP70', 'NFKB1']",0.42843454641782625,0,0,4
220,Ectoderm Differentiation WP2858,0.21971002380401347,1.4183989385227775,2.1495079561596,"['AHI1', 'PLCXD3', 'EDA', 'ZBTB16', 'STC1', 'NF2', 'CDH8', 'ANKS1B']",0.42843454641782625,0,0,8
221,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.2258281353609808,1.4064912280701753,2.092832269061131,"['RET', 'RYR2', 'PRKAR2B', 'CDCA7L', 'SP3', 'RORA', 'NR3C1', 'NFKB1']",0.43837226275955093,0,0,8
222,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.2294359773534375,2.340586016826226,3.4456498284664625,"['PTGS2', 'NFKB1']",0.44138131966199406,0,0,2
223,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2294359773534375,2.340586016826226,3.4456498284664625,"['GSK3B', 'PIK3CA']",0.44138131966199406,0,0,2
224,Oxidative Damage WP3941,0.23515884034056056,1.859284890426759,2.6913038660206046,"['MAPK10', 'MAP2K4', 'NFKB1']",0.44836952224933546,0,0,3
225,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.23515884034056056,1.859284890426759,2.6913038660206046,"['NFKBIA', 'GSK3B', 'NFKB1']",0.44836952224933546,0,0,3
226,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.2432502720199014,4.210951760104303,5.952872760314383,['PPARG'],0.45371463781103344,0,0,1
227,Fluoroacetic acid toxicity WP4966,0.2432502720199014,4.210951760104303,5.952872760314383,['ACSS2'],0.45371463781103344,0,0,1
228,FTO Obesity Variant Mechanism WP3407,0.2432502720199014,4.210951760104303,5.952872760314383,['ARID5B'],0.45371463781103344,0,0,1
229,Metabolism of alpha-linolenic acid WP4586,0.2432502720199014,4.210951760104303,5.952872760314383,['PTGS2'],0.45371463781103344,0,0,1
230,Peroxiredoxin 2 induced ovarian failure WP4873,0.2432502720199014,4.210951760104303,5.952872760314383,['MAPK10'],0.45371463781103344,0,0,1
231,Eicosanoid Synthesis WP167,0.24648952317104064,2.2172598598323483,3.1051300606710495,"['PTGS2', 'PTGES']",0.45395731752875856,0,0,2
232,Pregnane X receptor pathway WP2876,0.24648952317104064,2.2172598598323483,3.1051300606710495,"['NCOA1', 'NCOA2']",0.45395731752875856,0,0,2
233,Ciliary landscape WP4352,0.24655490672307867,1.2791406124739457,1.7910150340521052,"['MKLN1', 'CNOT6L', 'TBC1D4', 'WNK1', 'IFT140', 'EXOC6B', 'BBS9', 'MCM10', 'CEP170', 'EFHC2', 'NFKB1', 'RPGR']",0.45395731752875856,0,0,12
234,Kit receptor signaling pathway WP304,0.24878989761855394,1.6212243254128071,2.255360583898515,"['PRKCB', 'FOS', 'JAK2', 'SOS1']",0.4561148123006822,0,0,4
235,Notch Signaling Pathway Netpath WP61,0.2588327245601365,1.5905364022522968,2.149726497464927,"['GSK3B', 'MAML2', 'JAK2', 'NFKB1']",0.47115673478175485,0,0,4
236,Glycogen Synthesis and Degradation WP500,0.2597766977057119,1.7557734204793027,2.3666647091985684,"['GYS2', 'GSK3B', 'PHKA1']",0.47115673478175485,0,0,3
237,1q21.1 copy number variation syndrome WP4905,0.2635841872904922,2.106266318537859,2.808458577170124,"['TJP1', 'AFDN']",0.47115673478175485,0,0,2
238,Constitutive Androstane Receptor Pathway WP2875,0.2635841872904922,2.106266318537859,2.808458577170124,"['NCOA1', 'NCOA2']",0.47115673478175485,0,0,2
239,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.2635841872904922,2.106266318537859,2.808458577170124,"['PTGS2', 'PTGES']",0.47115673478175485,0,0,2
240,Unfolded protein response WP4925,0.2635841872904922,2.106266318537859,2.808458577170124,"['EIF2AK3', 'CASP2']",0.47115673478175485,0,0,2
241,Nonalcoholic fatty liver disease WP4396,0.2702389426409928,1.328387898881061,1.73812747065824,"['GSK3B', 'PIK3CA', 'IRS1', 'AKT3', 'EIF2AK3', 'PIK3R3', 'PIK3CD', 'NFKB1']",0.4810477443692361,0,0,8
242,Aryl Hydrocarbon Receptor Netpath WP2586,0.2722107701158767,1.7082140964493906,2.222691665169348,"['RET', 'PTGS2', 'NFKB1']",0.4825554561145087,0,0,3
243,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.2776072695129496,3.508909169926119,4.496835050587239,['VEGFC'],0.4900967844487876,0,0,1
244,DNA Mismatch Repair WP531,0.28068116383914293,2.0058435906999876,2.548496295998252,"['POLD1', 'POLE']",0.49147844606935637,0,0,2
245,miRNA regulation of p53 pathway in prostate cancer WP3982,0.28068116383914293,2.0058435906999876,2.548496295998252,"['SESN3', 'PTEN']",0.49147844606935637,0,0,2
246,Hepatitis C and Hepatocellular Carcinoma WP3646,0.28470616847168323,1.6631578947368422,2.0894213021239345,"['SOS1', 'PTGS2', 'NFKB1']",0.49649978160305736,0,0,3
247,DNA Repair Pathways Full Network WP4946,0.2958667248928077,1.3175098554533509,1.6045243443038117,"['RAP1A', 'POLD1', 'CHEK1', 'REV1', 'REV3L', 'FANCC', 'POLE']",0.5088949705962733,0,0,7
248,Canonical and non-canonical Notch signaling WP3845,0.29774507603651423,1.9145502017564682,2.319511281066075,"['MAML2', 'ADAM10']",0.5088949705962733,0,0,2
249,Physiological and pathological hypertrophy of the heart WP1528,0.29774507603651423,1.9145502017564682,2.319511281066075,"['PRKCB', 'FOS']",0.5088949705962733,0,0,2
250,Signal Transduction of S1P Receptor WP26,0.29774507603651423,1.9145502017564682,2.319511281066075,"['PLCB3', 'AKT3']",0.5088949705962733,0,0,2
251,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.29774507603651423,1.9145502017564682,2.319511281066075,"['GSK3B', 'ZBTB16']",0.5088949705962733,0,0,2
252,G1 to S cell cycle control WP45,0.2996900218976517,1.4785524019472767,1.781665401089858,"['PRIM2', 'TFDP2', 'ORC1', 'POLE']",0.5101865848971928,0,0,4
253,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.3104063709270147,3.0074501769417026,3.51833465856586,['HSD11B2'],0.5201731762800363,0,0,1
254,HIF1A and PPARG regulation of glycolysis WP2456,0.3104063709270147,3.0074501769417026,3.51833465856586,['PPARG'],0.5201731762800363,0,0,1
255,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.3104063709270147,3.0074501769417026,3.51833465856586,['NFKB1'],0.5201731762800363,0,0,1
256,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.3104063709270147,3.0074501769417026,3.51833465856586,['NFKB1'],0.5201731762800363,0,0,1
257,Cannabinoid receptor signaling WP3869,0.31474374540655764,1.8311953683732547,2.116855396146816,"['MAPK10', 'PRKAR2B']",0.5245844272479829,0,0,2
258,Neural Crest Differentiation WP2064,0.3154843408624233,1.3682320300931048,1.5784557246480773,"['ITGB1', 'GSK3B', 'TCF4', 'NFKB1', 'SOX5']",0.5245844272479829,0,0,5
259,ATM Signaling Network in Development and Disease  WP3878,0.3224050738933086,1.5411764705882354,1.7445293589108848,"['CHEK1', 'PPM1D', 'NFKB1']",0.5340223038618895,0,0,3
260,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.3316479751647358,1.754786771105309,1.9367251488641244,"['NR3C1', 'JAK2']",0.5451225338914624,0,0,2
261,Signal transduction through IL1R WP4496,0.3316479751647358,1.754786771105309,1.9367251488641244,"['NFKBIA', 'NFKB1']",0.5451225338914624,0,0,2
262,Energy Metabolism WP1541,0.3349936234140282,1.5043884220354808,1.64526504335639,"['NCOA1', 'GSK3B', 'PPARG']",0.5485200933000691,0,0,3
263,15q11.2 copy number variation syndrome WP4940,0.3417181298024515,2.6313559322033897,2.8254685953422123,['CYFIP1'],0.5511168334032018,0,0,1
264,ATR Signaling WP3875,0.3417181298024515,2.6313559322033897,2.8254685953422123,['CHEK1'],0.5511168334032018,0,0,1
265,Leptin and adiponectin WP3934,0.3417181298024515,2.6313559322033897,2.8254685953422123,['ACACA'],0.5511168334032018,0,0,1
266,NLR Proteins WP288,0.3417181298024515,2.6313559322033897,2.8254685953422123,['ERBIN'],0.5511168334032018,0,0,1
267,TYROBP causal network in microglia WP3945,0.34757053353095685,1.469311445508436,1.5527502048742348,"['CD84', 'MAF', 'SFT2D2']",0.5536186944572528,0,0,3
268,Ethanol effects on histone modifications WP3996,0.34843134616190735,1.684490861618799,1.7759824099398582,"['KAT2B', 'ACSS2']",0.5536186944572528,0,0,2
269,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.34843134616190735,1.684490861618799,1.7759824099398582,"['MTMR2', 'EGR2']",0.5536186944572528,0,0,2
270,Monoamine GPCRs WP58,0.34843134616190735,1.684490861618799,1.7759824099398582,"['HTR1E', 'DRD1']",0.5536186944572528,0,0,2
271,MECP2 and Associated Rett Syndrome WP3584,0.3516471212030416,1.3588920790407026,1.4202149415885261,"['SP3', 'PTEN', 'IGF1R', 'FKBP5']",0.5566664760003869,0,0,4
272,Glycerophospholipid Biosynthetic Pathway WP2533,0.3650700257125976,1.6196023297850974,1.6320183511124686,"['PIK3CA', 'PIK3CD']",0.5693594669647732,0,0,2
273,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.3650700257125976,1.6196023297850974,1.6320183511124686,"['ADAMTS2', 'PLOD2']",0.5693594669647732,0,0,2
274,TNF-alpha signaling pathway WP231,0.36987054926709945,1.2688499739455859,1.2620009773417837,"['NFKBIA', 'MAP2K4', 'TAB2', 'SOS1', 'NFKB1']",0.5693594669647732,0,0,5
275,ACE Inhibitor Pathway WP554,0.3716099085084767,2.3388381862958134,2.3152407308951504,['NR3C2'],0.5693594669647732,0,0,1
276,Autosomal recessive Osteopetrosis pathways WP4788,0.3716099085084767,2.3388381862958134,2.3152407308951504,['NFKB1'],0.5693594669647732,0,0,1
277,Cytokines and Inflammatory Response WP530,0.3716099085084767,2.3388381862958134,2.3152407308951504,['IL15'],0.5693594669647732,0,0,1
278,EDA signaling in hair follicle development WP3930,0.3716099085084767,2.3388381862958134,2.3152407308951504,['EDA'],0.5693594669647732,0,0,1
279,LTF danger signal response pathway WP4478,0.3716099085084767,2.3388381862958134,2.3152407308951504,['NFKB1'],0.5693594669647732,0,0,1
280,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3716099085084767,2.3388381862958134,2.3152407308951504,['GNMT'],0.5693594669647732,0,0,1
281,Ciliopathies WP4803,0.37958104679111493,1.1632920293896554,1.1268660323260178,"['AHI1', 'DNAH11', 'IFT140', 'CSPP1', 'TTC21B', 'SPAG1', 'NEK1', 'BBS9', 'CEP78']",0.5763442610455066,0,0,9
282,Heart Development WP1591,0.3815425877317573,1.5595203558650035,1.502649018517864,"['VEGFC', 'FGF10']",0.5763442610455066,0,0,2
283,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.3815425877317573,1.5595203558650035,1.502649018517864,"['PIK3CA', 'BRAF']",0.5763442610455066,0,0,2
284,Sphingolipid pathway WP1422,0.3815425877317573,1.5595203558650035,1.502649018517864,"['SGPL1', 'PLPP1']",0.5763442610455066,0,0,2
285,Base Excision Repair WP4752,0.39782984360381013,1.5037299515106304,1.3860343521611764,"['POLD1', 'POLE']",0.5838865430138234,0,0,2
286,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.39782984360381013,1.5037299515106304,1.3860343521611764,"['PIK3CA', 'NFKB1']",0.5838865430138234,0,0,2
287,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.39782984360381013,1.5037299515106304,1.3860343521611764,"['NFKBIA', 'ERBIN']",0.5838865430138234,0,0,2
288,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.39782984360381013,1.5037299515106304,1.3860343521611764,"['RAP1A', 'TEAD1']",0.5838865430138234,0,0,2
289,Tumor suppressor activity of SMARCB1 WP4204,0.39782984360381013,1.5037299515106304,1.3860343521611764,"['SMARCD3', 'ARID1B']",0.5838865430138234,0,0,2
290,Cells and molecules involved in local acute inflammatory response  WP4493,0.4001460224849978,2.1048239895697525,1.927862475012201,['ITGB1'],0.5838865430138234,0,0,1
291,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.4001460224849978,2.1048239895697525,1.927862475012201,['TCF4'],0.5838865430138234,0,0,1
292,Farnesoid X receptor pathway WP2879,0.4001460224849978,2.1048239895697525,1.927862475012201,['FKBP5'],0.5838865430138234,0,0,1
293,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.4001460224849978,2.1048239895697525,1.927862475012201,['ZAP70'],0.5838865430138234,0,0,1
294,Vitamin B12 Disorders WP4271,0.4001460224849978,2.1048239895697525,1.927862475012201,['CUBN'],0.5838865430138234,0,0,1
295,IL-18 signaling pathway WP4754,0.4032204957598447,1.1194519428968914,1.0167665536991066,"['NFKBIA', 'SLC4A7', 'GSK3B', 'ALS2', 'PRKCB', 'EPB41', 'PTEN', 'FOS', 'PTGS2', 'ACACB', 'NFKB1']",0.586378280274486,0,0,11
296,Cardiac Progenitor Differentiation WP2406,0.4139146840343183,1.4517871612496625,1.2806147819517177,"['GSK3B', 'NRG1']",0.594830268256418,0,0,2
297,The influence of laminopathies on Wnt signaling WP4844,0.4139146840343183,1.4517871612496625,1.2806147819517177,"['GSK3B', 'PPARG']",0.594830268256418,0,0,2
298,Complement system WP2806,0.4139783270369334,1.238527871881737,1.0923093231710832,"['LAMA5', 'F11', 'LAMC1', 'KLKB1']",0.594830268256418,0,0,4
299,Calcium Regulation in the Cardiac Cell WP536,0.41457867181507924,1.151671320630749,1.0140379868884333,"['RYR2', 'PLCB3', 'ADCY9', 'PRKCB', 'PRKAR2B', 'ITPR2', 'SLC8A1']",0.594830268256418,0,0,7
300,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.42211876215320004,1.2889155662264906,1.111649175096171,"['GSK3B', 'KAT2B', 'PPARG']",0.6031230248927241,0,0,3
301,Genes targeted by miRNAs in adipocytes WP1992,0.4273878777794595,1.9133578286120658,1.6264752683502803,['PTBP2'],0.6031230248927241,0,0,1
302,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.4273878777794595,1.9133578286120658,1.6264752683502803,['GRM5'],0.6031230248927241,0,0,1
303,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.4273878777794595,1.9133578286120658,1.6264752683502803,['LDLRAP1'],0.6031230248927241,0,0,1
304,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.4273878777794595,1.9133578286120658,1.6264752683502803,['ITGAV'],0.6031230248927241,0,0,1
305,Fatty acid beta-oxidation WP143,0.4297819300121307,1.4033072236727588,1.185061149260706,"['ACSS2', 'CPT1B']",0.604512944180997,0,0,2
306,Spinal Cord Injury WP2431,0.43332036108684463,1.1696519586427843,0.9781541545880905,"['EPHA4', 'ACAN', 'FOS', 'PDYN', 'PTGS2']",0.6071791113209185,0,0,5
307,Joubert Syndrome WP4656,0.4345081286142704,1.2029917726252806,1.0027425158027716,"['AHI1', 'NIN', 'CSPP1', 'BBS9']",0.6071791113209185,0,0,4
308,Prader-Willi and Angelman Syndrome WP3998,0.4463701147601967,1.2382160707420222,0.9987535240473697,"['CYFIP1', 'NHLH2', 'SLC45A2']",0.6116543080136196,0,0,3
309,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4533941024436621,1.7538026944806606,1.3872466164935542,['RYR2'],0.6116543080136196,0,0,1
310,Cori Cycle WP1946,0.4533941024436621,1.7538026944806606,1.3872466164935542,['PFKP'],0.6116543080136196,0,0,1
311,Ganglio Sphingolipid Metabolism WP1423,0.4533941024436621,1.7538026944806606,1.3872466164935542,['ST8SIA1'],0.6116543080136196,0,0,1
312,GPR40 Pathway WP3958,0.4533941024436621,1.7538026944806606,1.3872466164935542,['PLCB3'],0.6116543080136196,0,0,1
313,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.4533941024436621,1.7538026944806606,1.3872466164935542,['CDK8'],0.6116543080136196,0,0,1
314,Hedgehog Signaling Pathway Netpath WP47,0.4533941024436621,1.7538026944806606,1.3872466164935542,['STK36'],0.6116543080136196,0,0,1
315,Homologous recombination WP186,0.4533941024436621,1.7538026944806606,1.3872466164935542,['POLD1'],0.6116543080136196,0,0,1
316,Major receptors targeted by epinephrine and norepinephrine WP4589,0.4533941024436621,1.7538026944806606,1.3872466164935542,['ADCY9'],0.6116543080136196,0,0,1
317,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4533941024436621,1.7538026944806606,1.3872466164935542,['STAG1'],0.6116543080136196,0,0,1
318,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4533941024436621,1.7538026944806606,1.3872466164935542,['NFKB1'],0.6116543080136196,0,0,1
319,p38 MAPK Signaling Pathway WP400,0.46081174545284037,1.3154373368146215,1.0191557036245005,"['MAP2K4', 'RPS6KA5']",0.6177757462477141,0,0,2
320,Parkinson's disease pathway WP2371,0.46081174545284037,1.3154373368146215,1.0191557036245005,"['CASP6', 'CASP2']",0.6177757462477141,0,0,2
321,DNA IR-damage and cellular response via ATR WP4016,0.4749099603087355,1.1376821848026037,0.8471523423362797,"['RMI1', 'CHEK1', 'PPM1D', 'MCPH1']",0.6341104893955758,0,0,4
322,Bladder cancer WP2828,0.4759523953039054,1.2754964791518317,0.9469763402229818,"['RPS6KA5', 'BRAF']",0.6341104893955758,0,0,2
323,Kennedy pathway from sphingolipids WP3933,0.47822067209624636,1.618794504061779,1.1941571795293262,['SGPL1'],0.63515996386777,0,0,1
324,IL-2 signaling pathway WP49,0.49083137355287043,1.2379050837045,0.880960902756241,"['FOS', 'SOS1']",0.6498970964635229,0,0,2
325,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.49356561882261685,1.147878787878788,0.8105165954140502,"['GSK3B', 'MAP2K4', 'SOS1']",0.6515066168458543,0,0,3
326,Cholesterol Biosynthesis Pathway WP197,0.5019210298051973,1.5030731979884522,1.036087117950781,['LSS'],0.6524973387467564,0,0,1
327,Dopaminergic Neurogenesis WP2855,0.5019210298051973,1.5030731979884522,1.036087117950781,['RET'],0.6524973387467564,0,0,1
328,ERK Pathway in Huntington's Disease WP3853,0.5019210298051973,1.5030731979884522,1.036087117950781,['RPS6KA5'],0.6524973387467564,0,0,1
329,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5019210298051973,1.5030731979884522,1.036087117950781,['PTEN'],0.6524973387467564,0,0,1
330,Type II diabetes mellitus WP1584,0.5019210298051973,1.5030731979884522,1.036087117950781,['IRS1'],0.6524973387467564,0,0,1
331,Male infertility WP4673,0.5125624083007766,1.0627242278618425,0.7102534621175192,"['DDX4', 'HORMAD1', 'CDC42BPA', 'CLOCK', 'SOX5']",0.6636421999702541,0,0,5
332,p53 transcriptional gene network WP4963,0.516403185885199,1.1074647402820776,0.7318873995562747,"['SESN1', 'PTEN', 'FANCC']",0.6636421999702541,0,0,3
333,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5197757090676116,1.1689875253843922,0.7649362095786777,"['MAP2K4', 'CASP6']",0.6636421999702541,0,0,2
334,Hematopoietic Stem Cell Differentiation WP2849,0.5197757090676116,1.1689875253843922,0.7649362095786777,"['GYPA', 'FOS']",0.6636421999702541,0,0,2
335,Lung fibrosis WP3624,0.5197757090676116,1.1689875253843922,0.7649362095786777,"['ELN', 'FAM13A']",0.6636421999702541,0,0,2
336,Vitamin B12 metabolism WP1533,0.5197757090676116,1.1689875253843922,0.7649362095786777,"['CUBN', 'NFKB1']",0.6636421999702541,0,0,2
337,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.5245462004356137,1.402781399391569,0.9051050978664466,['SYTL1'],0.6657701774759712,0,0,1
338,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.5245462004356137,1.402781399391569,0.9051050978664466,['JARID2'],0.6657701774759712,0,0,1
339,Glucocorticoid Receptor Pathway WP2880,0.5276124815327351,1.0883029073698445,0.6958534798512821,"['TGFBR3', 'NR3C1', 'PTGS2']",0.6676865916741692,0,0,3
340,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5461448999405304,1.315026075619296,0.79542107681451,['NFKB1'],0.6869006394415123,0,0,1
341,GDNF/RET signaling axis WP4830,0.5461448999405304,1.315026075619296,0.79542107681451,['RET'],0.6869006394415123,0,0,1
342,NO/cGMP/PKG mediated Neuroprotection WP4008,0.5475991111631636,1.1073244468874537,0.666843857998828,"['NFKBIA', 'NFKB1']",0.6869006394415123,0,0,2
343,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5667636399238404,1.2375949075849375,0.7027223819279943,['BRAF'],0.7047582652966015,0,0,1
344,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5667636399238404,1.2375949075849375,0.7027223819279943,['NFKB1'],0.7047582652966015,0,0,1
345,Nanomaterial induced apoptosis WP2507,0.5667636399238404,1.2375949075849375,0.7027223819279943,['CASP6'],0.7047582652966015,0,0,1
346,Integrated Cancer Pathway WP1971,0.5742724700719338,1.0518276762402088,0.5833975972104303,"['CHEK1', 'PTEN']",0.7120314730082649,0,0,2
347,Nucleotide metabolism WP404,0.5864468268517592,1.1687672026655078,0.6237398228663411,['POLD1'],0.7217681220239905,0,0,1
348,Netrin-UNC5B signaling pathway WP4747,0.5871726680335028,1.0261096605744124,0.5463380813802556,"['PIK3CA', 'NEO1']",0.7217681220239905,0,0,2
349,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.5871726680335028,1.0261096605744124,0.5463380813802556,"['MAP2K4', 'FOS']",0.7217681220239905,0,0,2
350,Wnt signaling pathway and pluripotency WP399,0.5970366101580082,0.9669013660708913,0.4987053349759093,"['MAPK10', 'MAP2K4', 'GSK3B', 'PRKCB']",0.7289118822122552,0,0,4
351,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.5997806396758184,1.0016163123212731,0.5120175359368849,"['SOAT1', 'LSS']",0.7289118822122552,0,0,2
352,Nucleotide Excision Repair WP4753,0.5997806396758184,1.0016163123212731,0.5120175359368849,"['POLD1', 'POLE']",0.7289118822122552,0,0,2
353,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5997806396758184,1.0016163123212731,0.5120175359368849,"['LAG3', 'NFKB1']",0.7289118822122552,0,0,2
354,Purine metabolism and related disorders WP4224,0.6052368575164151,1.1071845193165444,0.555956538757482,['GRM5'],0.7313989066888509,0,0,1
355,Triacylglyceride synthesis WP325,0.6052368575164151,1.1071845193165444,0.555956538757482,['PLPP1'],0.7313989066888509,0,0,1
356,Angiogenesis WP1539,0.6231742099761846,1.0517601043024771,0.49740803159312597,['PIK3CA'],0.7375965938062629,0,0,1
357,Differentiation of white and brown adipocyte WP2895,0.6231742099761846,1.0517601043024771,0.49740803159312597,['PPARG'],0.7375965938062629,0,0,1
358,IL-7 signaling pathway WP205,0.6231742099761846,1.0517601043024771,0.49740803159312597,['GSK3B'],0.7375965938062629,0,0,1
359,Immune response to tuberculosis WP4197,0.6231742099761846,1.0517601043024771,0.49740803159312597,['JAK2'],0.7375965938062629,0,0,1
360,Kallmann's Syndrome WP5074,0.6231742099761846,1.0517601043024771,0.49740803159312597,['PIK3CA'],0.7375965938062629,0,0,1
361,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.6231742099761846,1.0517601043024771,0.49740803159312597,['GSK3B'],0.7375965938062629,0,0,1
362,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6241201947591455,0.9559696178495134,0.45065584522384666,"['PPP1R16B', 'EIF2AK3']",0.7375965938062629,0,0,2
363,Proximal tubule transport WP4917,0.6241201947591455,0.9559696178495134,0.45065584522384666,"['SLC47A1', 'SLC4A2']",0.7375965938062629,0,0,2
364,Exercise-induced Circadian Regulation WP410,0.6358533898998744,0.9346678270960256,0.42320568560085237,"['TAB2', 'CLOCK']",0.7464338050520196,0,0,2
365,NAD+ biosynthetic pathways WP3645,0.6402975297415926,1.0016142050040355,0.4465419690557177,['TNKS'],0.7464338050520196,0,0,1
366,Nanoparticle triggered autophagic cell death WP2509,0.6402975297415926,1.0016142050040355,0.4465419690557177,['UVRAG'],0.7464338050520196,0,0,1
367,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6402975297415926,1.0016142050040355,0.4465419690557177,['FOS'],0.7464338050520196,0,0,1
368,Statin inhibition of cholesterol production WP430,0.6402975297415926,1.0016142050040355,0.4465419690557177,['SOAT1'],0.7464338050520196,0,0,1
369,Cytosolic DNA-sensing pathway WP4655,0.6472974755340005,0.9142922011579067,0.3976707651699525,"['NFKBIA', 'NFKB1']",0.7525490975720494,0,0,2
370,Sphingolipid Metabolism (general overview) WP4725,0.6566437132409787,0.956027023823634,0.40211806473165174,['SGPL1'],0.7613517648118374,0,0,1
371,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.6722479866811544,0.9144039453545717,0.363135390564747,['PPARG'],0.7731752983544645,0,0,1
372,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6722479866811544,0.9144039453545717,0.363135390564747,['SOX5'],0.7731752983544645,0,0,1
373,Sphingolipid Metabolism (integrated pathway) WP4726,0.6722479866811544,0.9144039453545717,0.363135390564747,['SGPL1'],0.7731752983544645,0,0,1
374,Nuclear Receptors Meta-Pathway WP2882,0.6742310213866987,0.8975486548045915,0.35379794129615005,"['NCOA1', 'TGFBR3', 'NCOA2', 'KAT2B', 'NRG1', 'SMARCA1', 'PTGS2', 'NR3C1', 'SLC5A3', 'FKBP5']",0.7733826421788602,0,0,10
375,Translation Factors WP107,0.6799174780805782,0.8581552725528854,0.3310624397428706,"['EIF2AK3', 'EIF4G3']",0.7777962215928117,0,0,2
376,Genes related to primary cilium development (based on CRISPR) WP4536,0.6859328319411132,0.8577839512768458,0.3233635928305524,"['IFT140', 'TTC21B', 'SASS6', 'BBS9']",0.7777962215928117,0,0,4
377,Monoamine Transport WP727,0.6871439813139292,0.8762494567579313,0.3287788107703177,['AMPH'],0.7777962215928117,0,0,1
378,Photodynamic therapy-induced unfolded protein response WP3613,0.6871439813139292,0.8762494567579313,0.3287788107703177,['EIF2AK3'],0.7777962215928117,0,0,1
379,Striated Muscle Contraction Pathway WP383,0.6871439813139292,0.8762494567579313,0.3287788107703177,['MYOM1'],0.7777962215928117,0,0,1
380,Genotoxicity pathway WP4286,0.6902294162689591,0.8409399477806788,0.3117627174322077,"['RAPGEF2', 'PPM1D']",0.7792326831036407,0,0,2
381,PPAR signaling pathway WP3942,0.7002661435879851,0.824399733783853,0.2937293473968964,"['PPARG', 'CPT1B']",0.781519669685161,0,0,2
382,16p11.2 distal deletion syndrome WP4950,0.7013638061277085,0.8411473272490222,0.298378967470754,['JAK2'],0.781519669685161,0,0,1
383,7-oxo-C and 7beta-HC pathways WP5064,0.7013638061277085,0.8411473272490222,0.298378967470754,['HSD11B2'],0.781519669685161,0,0,1
384,SARS-CoV-2 mitochondrial interactions WP5038,0.7013638061277085,0.8411473272490222,0.298378967470754,['NFKB1'],0.781519669685161,0,0,1
385,Toll-like Receptor Signaling related to MyD88 WP3858,0.7013638061277085,0.8411473272490222,0.298378967470754,['NFKB1'],0.781519669685161,0,0,1
386,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7100313647774898,0.808495681863828,0.27686622075512873,"['CHEK1', 'MCPH1']",0.7884536032816354,0,0,2
387,Gastric Cancer Network 2 WP2363,0.7149381157961683,0.8087453615484906,0.27138202041832205,['AHCTF1'],0.7884536032816354,0,0,1
388,Intraflagellar transport proteins binding to dynein WP4532,0.7149381157961683,0.8087453615484906,0.27138202041832205,['IFT140'],0.7884536032816354,0,0,1
389,Type II interferon signaling (IFNG) WP619,0.7149381157961683,0.8087453615484906,0.27138202041832205,['JAK2'],0.7884536032816354,0,0,1
390,Pyrimidine metabolism WP4022,0.7255724061686883,0.7979647555224622,0.2559826328600873,"['PRIM2', 'POLD1', 'POLE']",0.7945736897337428,0,0,3
391,Aryl Hydrocarbon Receptor Pathway WP2873,0.7278961773085336,0.7787435414554058,0.24732649926184683,['NCOA1'],0.7945736897337428,0,0,1
392,Endothelin Pathways WP2197,0.7278961773085336,0.7787435414554058,0.24732649926184683,['NPY'],0.7945736897337428,0,0,1
393,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7278961773085336,0.7787435414554058,0.24732649926184683,['TGFBR3'],0.7945736897337428,0,0,1
394,Autophagy WP4923,0.7402659324606642,0.7508847085118272,0.22582541422289582,['UVRAG'],0.8060255965117384,0,0,1
395,Prion disease pathway WP3995,0.7520740572792479,0.7249471743919436,0.2065522965084919,['NFKB1'],0.8168095457539174,0,0,1
396,Neovascularisation processes WP4331,0.763346020185883,0.7007388092133855,0.18923020652152836,['NFKB1'],0.8248751704275664,0,0,1
397,Wnt signaling in kidney disease WP4150,0.763346020185883,0.7007388092133855,0.18923020652152836,['MAPK10'],0.8248751704275664,0,0,1
398,Amyotrophic lateral sclerosis (ALS) WP2447,0.7843776176149213,0.656861147327249,0.1595283982758825,['ALS2'],0.8412449948920031,0,0,1
399,CAMKK2  Pathway WP4874,0.7843776176149213,0.656861147327249,0.1595283982758825,['MAF'],0.8412449948920031,0,0,1
400,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7843776176149213,0.656861147327249,0.1595283982758825,['PTGS2'],0.8412449948920031,0,0,1
401,DNA damage response WP707,0.7936974450422984,0.6776720289733008,0.15657811596311136,"['SESN1', 'CHEK1']",0.8454202164248854,0,0,2
402,Pre-implantation embryo WP3527,0.7941826275506499,0.6369167555608234,0.1467722656857283,['NR3C2'],0.8454202164248854,0,0,1
403,Target Of Rapamycin (TOR) Signaling WP1471,0.7941826275506499,0.6369167555608234,0.1467722656857283,['RICTOR'],0.8454202164248854,0,0,1
404,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8035423237564386,0.6181455633100698,0.1352041485409504,['ITPR2'],0.8532664774542381,0,0,1
405,miRNA regulation of DNA damage response WP1530,0.8076241131790104,0.6564131853785901,0.1402482796508234,"['SESN1', 'CHEK1']",0.8554833198859148,0,0,2
406,Differentiation Pathway WP2848,0.8124769056839721,0.6004470106165022,0.12469350307983698,['FGF10'],0.8585039225084337,0,0,1
407,Hedgehog Signaling Pathway WP4249,0.821005657940968,0.5837317108503549,0.1151266489672386,['SMURF2'],0.8648474440611422,0,0,1
408,22q11.2 copy number variation syndrome WP4657,0.8225122544917156,0.6700041718815186,0.13091338639344835,"['AIFM3', 'TNPO1', 'FGF10']",0.8648474440611422,0,0,3
409,Glycolysis and Gluconeogenesis WP534,0.8291469912277175,0.5679199408012967,0.10640424662710654,['PFKP'],0.8677243736204712,0,0,1
410,mRNA Processing WP411,0.8292936904065109,0.6880096129087632,0.12878226948570196,"['CPSF1', 'SREK1', 'CLASRP', 'PTBP2']",0.8677243736204712,0,0,4
411,Selenium Micronutrient Network WP15,0.8329869148294538,0.6176470588235294,0.11286718394003584,"['PTGS2', 'NFKB1']",0.8694680935811087,0,0,2
412,"GPCRs, Class A Rhodopsin-like WP455",0.8426793598114037,0.6713717277486911,0.11491785904114354,"['HTR1E', 'RRH', 'NMUR2', 'DRD1']",0.877450110094884,0,0,4
413,Metabolic reprogramming in colon cancer WP4290,0.8514182970287781,0.5252281616688397,0.08448386123230722,['GLS'],0.8844030252429681,0,0,1
414,Notch Signaling WP268,0.8581779345918411,0.5123859191655802,0.07836625877732051,['KAT2B'],0.8892713380190816,0,0,1
415,Interleukin-11 Signaling Pathway WP2332,0.8646304241546701,0.5001552120196188,0.07274913540347511,['JAK2'],0.8916501249095035,0,0,1
416,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8646304241546701,0.5001552120196188,0.07274913540347511,['ACACA'],0.8916501249095035,0,0,1
417,Complement and Coagulation Cascades WP558,0.870789704764379,0.48849337497346956,0.06758538972524115,['KLKB1'],0.8958484013043612,0,0,1
418,Histone Modifications WP2369,0.8822812642557029,0.46672461248732433,0.05845463476707622,['KMT2E'],0.903338096338178,0,0,1
419,One-carbon metabolism and related pathways WP3940,0.8822812642557029,0.46672461248732433,0.05845463476707622,['GNMT'],0.903338096338178,0,0,1
420,Folate Metabolism WP176,0.892751994781735,0.44680851063829785,0.05068884297477517,['NFKB1'],0.9118823946699149,0,0,1
421,Allograft Rejection WP2328,0.9022924716591192,0.428518213021845,0.044058770067527564,['COL5A1'],0.9194381718331642,0,0,1
422,Pathogenic Escherichia coli infection WP2272,0.9067399550311697,0.4199217731421121,0.04111016474980818,['ITGB1'],0.921780665185715,0,0,1
423,"GPCRs, Other WP117",0.9326968927977213,0.3681923191289828,0.025653801551369336,['CELSR3'],0.9459266359579727,0,0,1
424,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9514358201068485,0.32777868318122555,0.01631782119744048,['RNF19A'],0.9626555821364103,0,0,1
425,NRF2 pathway WP2884,0.9613021571676823,0.3915717039603719,0.015453964615970183,"['NRG1', 'SLC5A3']",0.9703497068822018,0,0,2
426,Vitamin D Receptor Pathway WP2877,0.9728226541921032,0.36098856576933464,0.009946491380988997,"['EFNA5', 'SLC8A1']",0.9771686427979568,0,0,2
427,Amino Acid metabolism WP3925,0.9747241783672884,0.2687125998729649,0.006879241938436087,['GLS'],0.9771686427979568,0,0,1
428,Metapathway biotransformation Phase I and II WP702,0.9748908604138125,0.35482586184006726,0.009023133771591117,"['KCNAB3', 'HS3ST1']",0.9771686427979568,0,0,2
429,Cytoplasmic Ribosomal Proteins WP477,0.9826003067669715,0.24359479700433584,0.004275782213603069,['RPS6KA2'],0.9826003067669715,0,0,1
